Your browser is no longer supported. Please, upgrade your browser.
ILMN Illumina Inc. monthly Stock Chart
Illumina Inc.
IndexS&P 500 P/E47.50 EPS (ttm)2.91 Insider Own0.60% Shs Outstand147.67M Perf Week-4.85%
Market Cap20.41B Forward P/E35.47 EPS next Y3.90 Insider Trans-12.04% Shs Float144.87M Perf Month-22.58%
Income432.70M PEG3.25 EPS next Q0.87 Inst Own97.50% Short Float3.48% Perf Quarter-14.84%
Sales2.31B P/S8.82 EPS this Y30.50% Inst Trans0.05% Short Ratio3.85 Perf Half Y-0.30%
Book/sh14.01 P/B9.86 EPS next Y15.20% ROA11.40% Target Price143.73 Perf Year-6.41%
Cash/sh9.65 P/C14.32 EPS next 5Y14.62% ROE22.10% 52W Range127.10 - 196.47 Perf YTD-28.01%
Dividend- P/FCF41.48 EPS past 5Y28.90% ROI16.60% 52W High-29.67% Beta1.20
Dividend %- Quick Ratio3.10 Sales past 5Y19.70% Gross Margin70.00% 52W Low8.72% ATR5.76
Employees4600 Current Ratio3.70 Sales Q/Q11.30% Oper. Margin24.60% RSI (14)28.92 Volatility2.81% 2.82%
OptionableYes Debt/Eq0.50 EPS Q/Q18.60% Profit Margin18.70% Rel Volume0.88 Prev Close142.27
ShortableYes LT Debt/Eq0.50 EarningsNov 01 AMC Payout0.00% Avg Volume1.31M Price138.18
Recom2.70 SMA20-14.54% SMA50-17.67% SMA200-11.15% Volume1,145,900 Change-2.87%
Oct-11-16Reiterated Cantor Fitzgerald Hold $165 → $155
Oct-11-16Reiterated Canaccord Genuity Hold $165 → $136
Oct-11-16Downgrade Citigroup Buy → Neutral
Aug-22-16Downgrade CL King Buy → Neutral
Jul-27-16Reiterated Mizuho Neutral $138 → $148
Jul-05-16Downgrade Morgan Stanley Equal-Weight → Underweight $130 → $110
Jun-22-16Initiated CL King Buy
May-04-16Reiterated Stifel Buy $215 → $160
May-04-16Reiterated Mizuho Neutral $150 → $138
May-04-16Reiterated Canaccord Genuity Hold $160 → $140
May-03-16Reiterated UBS Buy $210 → $180
May-03-16Reiterated Morgan Stanley Overweight $140 → $130
Apr-19-16Downgrade Cantor Fitzgerald Buy → Hold
Apr-19-16Downgrade BofA/Merrill Buy → Neutral
Feb-04-16Downgrade Canaccord Genuity Buy → Hold $205 → $160
Feb-03-16Reiterated Deutsche Bank Hold $178 → $160
Jan-07-16Reiterated Barclays Equal Weight $170 → $175
Jan-07-16Initiated Deutsche Bank Hold $192
Jan-07-16Downgrade Wells Fargo Outperform → Market Perform
Dec-21-15Reiterated Stifel Buy $175 → $215
Oct-25-16 01:29PM  Baron Funds Comments on Illumina Inc.
12:20PM  Baron Opportunity Fund 3rd Quarter Commentary
Oct-24-16 04:05PM  German Court Issues Preliminary Injunction Against amedes Fetalis® Test for Infringement of Non-Invasive Prenatal Screening Patent Business Wire
08:15AM  Illumina (ILMN) Q3 Earnings: Disappointment in the Cards?
Oct-23-16 01:26PM  No Cure Yet for Breast Cancer, but 3 Big Advances in 2016 at Motley Fool
Oct-21-16 09:52PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Illumina Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
05:33PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Illumina Inc. Business Wire
04:12PM  Baron Funds Comments on Illumina
11:08AM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Illumina Inc. and Advises Investors with Losses to Contact the Firm Business Wire
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Illumina Inc. (ILMN) PR Newswire
Oct-20-16 05:29PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Illumina Inc. and Advises Investors with Losses to Contact the Firm Business Wire
04:12PM  INVESTOR ALERT: Investigation of Illumina Inc. Announced by Law Offices of Howard G. Smith Business Wire
09:00AM  Illumina Contributes to ClinVar Database Business Wire
Oct-19-16 01:08PM  The Holy GRAIL of Healthcare? Illumina Eyes Up A Potential $200 Billion Market at Motley Fool
12:56PM  What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers
10:15AM  New Strong Sell Stocks for October 19th
Oct-17-16 01:20PM  George Church-founded gene sequencing firm Veritas Genetics raises $30M at
09:50AM  Buy on the Dip? 3 Reasons to Buy Illumina and Never Sell at Motley Fool
Oct-15-16 07:04AM  These 3 Stocks Are Up Over 500% Over the Last 10 Years at Motley Fool
Oct-14-16 10:50AM  ETFs with exposure to Illumina, Inc. : October 14, 2016
Oct-13-16 05:02PM  Does a Clinton Victory Scare the Biotech Sector? (AMGN, ILMN) at Investopedia
10:41AM  Illumina Hurt By Lower Projected 3Q Sales (ILMN) at Investopedia
Oct-12-16 04:30PM  3 Warning Signs from Illumina, Inc.'s Q3 Preview at Motley Fool
04:06PM  Earnings Season On Deck: How Has Q3 Guidance Looked So Far?
04:01PM  Stocks Closed Mixed After Fed Minutes; Humana, HMOs Dive
03:45PM  Biotech Movers And Shakers: Vericel Corp (VCEL) and Illumina, Inc. (ILMN) at Insider Monkey
03:12PM  The market gets its first big genetically designed disaster at CNBC
12:10PM  The politics of health care
10:10AM  Company News for October 12, 2016
08:50AM  Illumina, Inc. breached its 50 day moving average in a Bearish Manner : ILMN-US : October 12, 2016
06:58AM  Alcoa stock slammed by earnings disaster as season gets off on the back foot at MarketWatch
02:02AM  GLOBAL MARKETS-Asia shares slip as US earnings disappoint, dollar gains Reuters
Oct-11-16 06:03PM  Indexes Tank But Apple, Twitter Stay Afloat; Lumentum, Illumina Dive -24.81%
05:15PM  Biotech bloodbath
04:59PM  Biotech Stocks Smacked For Biggest Decline in 3 1/2 Months at The Wall Street Journal
04:45PM  Illumina Leads Healthcare Selloff, Abbott and Zimmer Also Fall
04:42PM  Rent-A-Center, St. Jude Medical fall; Twilio, Tyson gain
04:40PM  GLOBAL MARKETS-Wall Street stocks slide, dollar hits 8-month high Reuters
04:31PM  US STOCKS-Wall St sells off on weak earnings, election fears
04:31PM  Supernus Stock Reverses Downward Despite Good ADHD Drug Trial
04:15PM  Illumina Stock Crashes On Troubling Outlook, Sales Miss
03:11PM  US STOCKS-Wall St sells off amid weak earnings, election jitters
02:53PM  GLOBAL MARKETS-Wall Street slides, dollar hits 8-month high Reuters
01:50PM  Illumina's Unfortunate Sequencing at Bloomberg
01:43PM  [$$] Illumina shares slide on sales 'credibility gap' at Financial Times
01:39PM  Illumina sinks on Q3 sales
01:38PM  Stocks Down, Nasdaq Gets Near 50-Day Line; Medicals Smacked, Apple Still Firm
12:54PM  Why Illumina, Inc. Is Plunging Today at Motley Fool
11:22AM  Dow Drops 173 Points As Alcoa, Illumina, Oil Weigh On Stocks at
11:01AM  Illumina Plunges 25% On Lower Q3 Sales; Janney Cuts To Sell at
10:59AM  Illumina's Pain Infects Biotech ETFs at
10:57AM  Illumina stock craters 26% after preliminary warning of revenue miss at MarketWatch
10:29AM  Illumina (ILMN) Stock Tanks After Lower Q3 Outlook, Downgrades
10:25AM  Alcoa Kicks Off Earnings Season With Miss; Apple Jumps On Galaxy Halt
10:19AM  Illumina shares plummet 25 percent after cutting revenue forecast at CNBC
10:15AM  Illumina is crashing after giving investors terrible news about its revenue
09:46AM  Why Twitter, Yahoo, Illumina, and Two Other Stocks Are Trending on Tuesday at Insider Monkey
09:44AM  Stock Open Lower; Apple, Caterpillar, Airlines Climb
09:25AM  Top Analyst Upgrades and Downgrades: Caterpillar, Illumina, Nike, Seagate, Twitter, Tyson Foods, Western Digital and More at 24/7 Wall St.
08:52AM  Stocks Cool as Oil Rally Fades at The Wall Street Journal
08:42AM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:35AM  Illumina Stumbles Over Q3 Sales Update
08:32AM  Morning Movers: ILMN, STJ, AA, MRO, CHK
08:09AM  Analysts' Actions -- Encana, Norfolk Southern, Seagate, Tyson and More
Oct-10-16 06:43PM  Edited Transcript of ILMN earnings conference call or presentation 10-Oct-16 8:30pm GMT
05:20PM  After-hours buzz: ILMN, VZ & more at CNBC
05:10PM  Illumina Again Preannounces Q3 Revenue Shortfall; Shares Plunge
05:08PM  Illumina Plunges 26% in Early Trading as Revenue Falls Short at Bloomberg
05:01PM  Illumina (ILMN) Stock Plunges in After-Hours Trading, Cuts Q3 Guidance
04:44PM  [$$] Gene-Sequencing Firm Illumina Cuts Revenue Guidance at The Wall Street Journal
04:39PM  Illumina cuts Q3 revenue estimates, shares down 23% at MarketWatch
04:30PM  Preliminary Q3 2016 Illumina Inc Earnings Call scheduled for 4:30 pm ET today
04:05PM  Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016 Business Wire
Oct-05-16 03:56PM  In Your 40s? 3 Stocks You Should Consider Buying at Motley Fool
Oct-04-16 11:32AM  Americas 15 Fastest Growing Companies
Oct-02-16 03:12PM  5 Trade Ideas for Monday: Alcoa, Illumina, Morgan Stanley, Schwab and Tiffany
Sep-29-16 09:34PM  Illuminas Venture Capital Fund Initiative (ILMN) at Investopedia
Sep-23-16 11:38AM  Top 5 profitable Biotech stocks : September 23, 2016
Sep-19-16 01:45PM  International Flavors and Fragrances to Acquire David Michael
08:25AM  RBC Says These 4 Top Biotechs Could Have Big Upside Potential at 24/7 Wall St.
Sep-17-16 09:30AM  How to Achieve Exponential Returns: Investing in the S-Curve at Motley Fool
Sep-08-16 08:00AM  Illumina Faces a Bumpy Ride for a Few Quarters
Aug-30-16 04:35PM  3 Stocks that Turned $7,000 into $63,000 in 10 Years at Motley Fool
03:30AM  Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference Business Wire
Aug-29-16 11:35AM  ETFs with exposure to Illumina, Inc. : August 29, 2016
08:49AM  Thermo Fisher to Buy Illumina? Not So Fast at Motley Fool
Aug-26-16 03:23PM  Illumina Keen on Genome Network Growth & Global Expansion
08:04AM  Whats behind Thermo Fishers Rumored Acquisition of Illumina?
Aug-25-16 02:20PM  Biotech building on the Peninsula bounces back and it needs space to grow at
Aug-23-16 05:42PM  3 Top Stocks You Can Buy and Hold for the Next Decade at Motley Fool
09:42AM  Illumina Rallies on Rumors of Takeover by Thermo Fisher
Aug-22-16 08:22AM  Illumina downgraded by CL King
Aug-19-16 11:54AM  Artificial Intelligence, Machine Learning, And The FDA at Forbes
Aug-18-16 06:00PM  Illumina Closes Slightly Up on Takeover Reports at Investopedia
04:52PM  Will Thermo Fisher Buy Illumina? Analyst Sees 'Close To A 0%' Chance
03:48PM  Illumina Shares Gain 2%, Cooling Speculation of a Thermo Fisher Buyout
12:51PM  Illumina (ILMN) Stock Gains on Thermo Fisher Takeover Speculation
12:26PM  Illumina Pops on Takeover -- One Chart Gives it Perspective
12:23PM  Illumina: Back in Bidness? at Bloomberg
12:07PM  Illumina: Takeover Speculation 'Makes No Sense' at
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company's sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRADBURY DANIELDirectorOct 07Option Exercise71.0960042,65417,065Oct 11 08:35 PM
BRADBURY DANIELDirectorOct 07Sale184.36600110,61316,465Oct 11 08:35 PM
Dadswell CharlesSr VP & General CounselOct 04Sale182.3811621,15639,900Oct 06 05:32 PM
EPSTEIN ROBERT SDirectorSep 20Sale174.2930052,2876,924Sep 21 06:56 PM
Stapley MarcEVP & Chief Administrative OfcSep 15Sale172.871,270219,54332,746Sep 16 08:07 PM
BRADBURY DANIELDirectorSep 14Option Exercise71.0960042,65417,065Sep 16 07:58 PM
BRADBURY DANIELDirectorSep 14Sale171.25600102,74816,465Sep 16 07:58 PM
Dadswell CharlesSr VP & General CounselSep 06Sale168.0111619,48940,016Sep 08 07:58 PM
FLATLEY JAY TDirectorAug 23Option Exercise36.3020,000726,000508,061Aug 25 08:43 PM
FLATLEY JAY TDirectorAug 23Sale172.9920,0003,459,877488,061Aug 25 08:43 PM
EPSTEIN ROBERT SDirectorAug 22Sale170.2730051,0817,224Aug 23 08:19 PM
EPSTEIN ROBERT SDirectorAug 22Sale170.2730051,0817,224Aug 24 07:52 PM
BRADBURY DANIELDirectorAug 17Option Exercise71.0960042,65417,065Aug 18 08:31 PM
BRADBURY DANIELDirectorAug 17Sale168.42600101,05316,465Aug 18 08:31 PM
FLATLEY JAY TDirectorAug 15Option Exercise36.3010,000363,000498,061Aug 16 06:56 PM
FLATLEY JAY TDirectorAug 15Sale170.0010,0001,700,000488,061Aug 16 06:56 PM
WHITFIELD ROY ADirectorAug 12Option Exercise42.824,000171,2806,853Aug 15 06:03 PM
WHITFIELD ROY ADirectorAug 12Sale167.224,000668,8802,853Aug 15 06:03 PM
FLATLEY JAY TDirectorAug 09Option Exercise36.3010,000363,000498,061Aug 10 09:40 PM
FLATLEY JAY TDirectorAug 09Sale165.9710,0001,659,650488,061Aug 10 09:40 PM
Dadswell CharlesSr VP & General CounselAug 04Sale164.6311619,09740,132Aug 08 06:36 PM
FLATLEY JAY TDirectorAug 01Option Exercise36.3010,000363,000498,061Aug 02 07:27 PM
FLATLEY JAY TDirectorAug 01Sale170.0010,0001,700,000488,061Aug 02 07:27 PM
Dadswell CharlesSr VP & General CounselJul 27Sale155.008,6321,337,96040,248Jul 28 07:44 PM
FLATLEY JAY TDirectorJul 26Option Exercise36.3010,000363,000498,061Jul 28 07:39 PM
FLATLEY JAY TDirectorJul 26Sale150.0010,0001,500,000488,061Jul 28 07:39 PM
EPSTEIN ROBERT SDirectorJul 20Sale150.0030045,0007,524Jul 20 08:08 PM
FLATLEY JAY TDirectorJul 18Option Exercise36.3010,000363,000498,061Jul 20 08:06 PM
EPSTEIN ROBERT SDirectorJul 18Sale150.00900135,0007,824Jul 20 08:08 PM
FLATLEY JAY TDirectorJul 18Sale150.0010,0001,500,010488,061Jul 20 08:06 PM
BOWMAN A BLAINEDirectorJul 14Option Exercise42.825,000214,10020,704Jul 15 06:53 PM
BOWMAN A BLAINEDirectorJul 14Sale147.145,000735,70515,704Jul 15 06:53 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerJul 11Sale141.89716101,59318,976Jul 12 07:47 PM
BOWMAN A BLAINEDirectorJun 16Option Exercise42.825,000214,10020,704Jun 17 07:53 PM
BOWMAN A BLAINEDirectorJun 16Sale135.085,000675,38815,704Jun 17 07:53 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerJun 15Sale137.902,141295,24219,692Jun 15 06:47 PM
WHITFIELD ROY ADirectorJun 13Option Exercise42.822,00085,6406,653Jun 15 06:34 PM
WHITFIELD ROY ADirectorJun 13Sale140.443,800533,6722,853Jun 15 06:34 PM
EASTHAM KARINDirectorJun 01Option Exercise36.295,000181,45017,424Jun 03 07:28 PM
EASTHAM KARINDirectorJun 01Sale145.355,000726,75012,424Jun 03 07:28 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMay 25Sale144.732,141309,86721,833May 26 07:44 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMay 17Sale140.842,141301,53223,974May 19 06:56 PM
BOWMAN A BLAINEDirectorMay 12Option Exercise36.295,000181,45018,615May 13 06:03 PM
BOWMAN A BLAINEDirectorMay 12Sale137.115,000685,53513,615May 13 06:03 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 27Sale138.462,141296,44626,115Apr 28 06:34 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 18Sale176.012,141376,83528,256Apr 20 05:57 PM
Bianchi Paul LSr. VP, Human ResourcesApr 18Sale175.001,884329,70065,660Apr 20 05:33 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 13Option Exercise37.0412,500463,00042,897Apr 14 06:43 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 13Sale175.0012,5002,187,50030,397Apr 14 06:43 PM
WHITFIELD ROY ADirectorApr 12Option Exercise42.824,000171,2805,800Apr 14 06:21 PM
FLATLEY JAY TChief Executive OfficerApr 12Option Exercise36.3020,000726,000508,061Apr 14 06:42 PM
FLATLEY JAY TChief Executive OfficerApr 12Sale170.0520,0003,401,014488,061Apr 14 06:42 PM
WHITFIELD ROY ADirectorApr 12Sale170.004,000680,0001,800Apr 14 06:21 PM
WALT DAVID RDirectorApr 07Option Exercise13.304,00053,200635,840Apr 11 05:58 PM
WALT DAVID RDirectorApr 07Sale168.904,000675,596631,840Apr 11 05:58 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 05Sale166.072,141355,54630,397Apr 06 05:29 PM
Dadswell CharlesSr VP & General CounselApr 04Sale167.818,3821,406,60449,859Apr 06 05:19 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMar 23Sale155.052,141331,95732,538Mar 23 05:41 PM
FLATLEY JAY TChief Executive OfficerMar 22Option Exercise36.3010,000363,000498,061Mar 23 05:39 PM
FLATLEY JAY TChief Executive OfficerMar 22Sale154.1810,0001,541,759488,061Mar 23 05:39 PM
BRADBURY DANIELDirectorMar 21Option Exercise44.511,20053,41215,576Mar 22 02:51 PM
Naclerio NicholasSr VP, Corporate DevelopmentMar 21Sale154.254,520697,21030,020Mar 22 02:48 PM
BRADBURY DANIELDirectorMar 21Sale155.631,200186,75614,376Mar 22 02:51 PM
BOWMAN A BLAINEDirectorMar 17Option Exercise36.295,000181,45018,615Mar 18 08:49 PM
BOWMAN A BLAINEDirectorMar 17Sale145.245,000726,19213,615Mar 18 08:49 PM
WALT DAVID RDirectorMar 15Option Exercise13.304,00053,200635,840Mar 16 09:16 PM
WALT DAVID RDirectorMar 15Sale149.994,000599,961631,840Mar 16 09:16 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMar 14Sale155.915,892918,61834,679Mar 15 07:42 PM
OSTADAN OMEADEVP Ops, Products, StrategyMar 09Sale150.32871130,92955,189Mar 11 11:43 AM
FLATLEY JAY TChief Executive OfficerMar 08Option Exercise36.3010,000363,000500,915Mar 09 06:45 PM
Dadswell CharlesSr VP & General CounselMar 08Sale155.648,2661,286,51758,241Mar 09 06:38 PM
FLATLEY JAY TChief Executive OfficerMar 08Sale154.4910,0001,544,864490,915Mar 09 06:45 PM
OSTADAN OMEADEVP Ops, Products, StrategyMar 08Sale156.094,516704,90256,060Mar 09 06:52 PM
Dadswell CharlesSr VP & General CounselMar 07Sale155.0011617,98066,507Mar 09 06:38 PM
Stapley MarcEVP & Chief Administrative OfcMar 03Option Exercise0.0024,000040,801Mar 07 08:11 PM
FLATLEY JAY TChief Executive OfficerMar 03Option Exercise0.0083,8300514,614Mar 07 08:09 PM
deSouza Francis APresidentMar 03Option Exercise0.0049,2190118,880Mar 07 08:07 PM
Ronaghi MostafaSr VP & CTOMar 03Option Exercise0.0020,063062,763Mar 07 08:05 PM
ORPIN TRISTANEVP Clinical GenomicsMar 03Option Exercise0.0024,0000125,797Mar 07 08:02 PM
Naclerio NicholasSr VP, Corporate DevelopmentMar 03Option Exercise0.0020,063040,866Mar 07 08:00 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMar 03Option Exercise0.0024,000047,536Mar 07 07:58 PM
Dadswell CharlesSr VP & General CounselMar 03Option Exercise0.0033,750075,325Mar 07 07:56 PM
Bouchard MichelChief Accounting OfficerMar 03Option Exercise0.008,250023,746Mar 07 08:14 PM
FLATLEY JAY TChief Executive OfficerFeb 23Option Exercise36.3010,000363,000440,784Feb 25 07:05 PM
FLATLEY JAY TChief Executive OfficerFeb 23Sale152.4910,0001,524,850430,784Feb 25 07:05 PM
BRADBURY DANIELDirectorFeb 17Option Exercise44.511,70075,66716,076Feb 19 11:27 AM
BRADBURY DANIELDirectorFeb 17Sale154.741,700263,05114,376Feb 19 11:27 AM
OSTADAN OMEADEVP Ops, Products, StrategyFeb 01Sale156.731,108173,65746,476Feb 03 06:58 PM
FLATLEY JAY TChief Executive OfficerJan 26Option Exercise36.3020,000726,000453,423Jan 28 06:09 PM
FLATLEY JAY TChief Executive OfficerJan 26Sale171.7020,0003,434,082433,423Jan 28 06:09 PM
BRADBURY DANIELDirectorJan 04Option Exercise44.511,70075,66716,076Jan 04 06:33 PM
BRADBURY DANIELDirectorJan 04Sale182.801,700310,75614,376Jan 04 06:33 PM
Dadswell CharlesSr VP & General CounselDec 28Sale188.6316831,69041,830Dec 30 02:36 PM
FLATLEY JAY TChief Executive OfficerDec 22Option Exercise31.3025,000782,550458,423Dec 24 10:54 AM
FLATLEY JAY TChief Executive OfficerDec 22Sale185.3825,0004,634,560433,423Dec 24 10:54 AM
WHITFIELD ROY ADirectorDec 14Option Exercise36.293,750136,08817,398Dec 15 05:40 PM
WHITFIELD ROY ADirectorDec 14Sale175.073,750656,51313,648Dec 15 05:40 PM
Bianchi Paul LSr. VP, Human ResourcesDec 11Sale179.9019735,44059,827Dec 14 05:48 PM
OSTADAN OMEADEVP Ops, Products, StrategyDec 11Sale179.9026046,77448,293Dec 14 05:46 PM
BRADBURY DANIELDirectorDec 10Option Exercise44.511,70075,66716,076Dec 11 06:47 PM